Showing results (461-470 of 478) with videos related to

Sort By:
Pageof 48
Molecular Oncology|October 31, 2024
Minimally invasive determination of pancreatic ductal adenocarcinoma (PDAC) subtype by means of circulating cell-free RNAMartin Metzenmacher, Gregor Zaun, Marija Trajkovic-Arsic, et al.
Microorganisms|March 6, 2021
Identification of Beneficial Microbial Consortia and Bioactive Compounds with Potential as Plant Biostimulants for a Sustainable AgricultureSilvia Tabacchioni, Stefania Passato, Patrizia Ambrosino, et al.
JCO Precision Oncology|September 11, 2020
Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic MelanomaRenáta Váraljai, Kilian Wistuba-Hamprecht, Teofila Seremet, et al.
German Medical Science : GMS E-Journal|July 1, 2021
Advisory opinion of the AWMF Ad hoc Commission In-vitro Diagnostic Medical Devices regarding in-vitro diagnostic medical devices manufactured and used only within health institutions established in the Union according to Regulation (EU) 2017/746 (IVDR)Petra Hoffmüller, Monika Brüggemann, Thomas Eggermann, et al.
Haematologica|August 13, 2013
Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international studyMarjolein Blink, Martin Zimmermann, Christine von Neuhoff, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 19, 2014
In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effectsErik Sjögren, Bertil Abrahamsson, Patrick Augustijns, et al.
Cancers|June 2, 2021
Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COGMareike Rasche, Martin Zimmermann, Emma Steidel, et al.
Pediatric Blood & Cancer|September 17, 2021
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 StudyKim Klein, H Berna Beverloo, Martin Zimmermann, et al.
ALTEX|June 11, 2020
New approach methodologies (NAMs) for human-relevant biokinetics predictions. Meeting the paradigm shift in toxicology towards an animal-free chemical risk assessmentAns Punt, Hans Bouwmeester, Bas J Blaauboer, et al.
Leukemia|May 18, 2022
Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolutionPaulina Richter-Pechańska, Joachim B Kunz, Tobias Rausch, et al.
Pageof 48